XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.910
+0.020 (0.69%)
Jul 10, 2026, 4:00 PM EDT - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.54 million as of July 10, 2026. Its market cap has decreased by -36.63% in one year.
Market Cap
6.54M
Enterprise Value
6.46M
1-Year Change
-36.63%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $6.54M, a decrease of -96.57%. That is a compound annual growth rate of -14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 6.54M | -8.21% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 7.07M |
| Acurx Pharmaceuticals | 6.45M |
| Aptorum Group | 6.37M |
| Addex Therapeutics | 6.36M |
| BioAtla | 6.34M |
| Curanex Pharmaceuticals | 6.32M |
| Pulmatrix | 6.28M |
| Xenetic Biosciences | 6.27M |